An international perspective on advanced neuroimaging: cometh the hour or ivory tower?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F11%3A7100" target="_blank" >RIV/00064203:_____/11:7100 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/11:7100

Výsledek na webu

<a href="http://www.ncbi.nlm.nih.gov/pubmed/21843380" target="_blank" >http://www.ncbi.nlm.nih.gov/pubmed/21843380</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

An international perspective on advanced neuroimaging: cometh the hour or ivory tower?

Popis výsledku v původním jazyce

Over the past five to ten years, neuroimaging capability for neurodegenerative diseases has made remarkable progress. However, debate remains as to the true clinical utility of these advanced and costly investigations. Not only is the place of these tests in diagnostic algorithms unclear, but the access to them varies both within and between countries. We sought to gather informed opinion from recognized leaders in the field who can combine both an academic and a clinical perspective on the use of neuroimaging in their own countries. Opinion is presented from Scotland, Argentina, the Czech Republic, France, the USA and Australia. The emerging consensus was one of ongoing caution. While in most countries there was a sense that the use of more advanced imaging techniques was growing, their hour has not yet cometh. However, these techniques, rather than falling from the Ivory Tower, should descend slowly step by step onto fertile and receptive clinics from where better clinical guidelines

Název v anglickém jazyce

An international perspective on advanced neuroimaging: cometh the hour or ivory tower?

Popis výsledku anglicky

Over the past five to ten years, neuroimaging capability for neurodegenerative diseases has made remarkable progress. However, debate remains as to the true clinical utility of these advanced and costly investigations. Not only is the place of these tests in diagnostic algorithms unclear, but the access to them varies both within and between countries. We sought to gather informed opinion from recognized leaders in the field who can combine both an academic and a clinical perspective on the use of neuroimaging in their own countries. Opinion is presented from Scotland, Argentina, the Czech Republic, France, the USA and Australia. The emerging consensus was one of ongoing caution. While in most countries there was a sense that the use of more advanced imaging techniques was growing, their hour has not yet cometh. However, these techniques, rather than falling from the Ivory Tower, should descend slowly step by step onto fertile and receptive clinics from where better clinical guidelines

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

AN - Psychologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

International Psychogeriatrics

ISSN

1041-6102

e-ISSN

—

Svazek periodika

23

Číslo periodika v rámci svazku

—

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

"S58"-"S64"

Kód UT WoS článku

000294978200008

EID výsledku v databázi Scopus

—